Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bio-Techne Corp announces agreement to acquire Novus Biologicals

Wednesday, 2 Jul 2014 04:15pm EDT 

Techne Corp:Acquires Novus Biologicals for $60 mln in cash.Transaction was financed with cash on hand.Fredrikson & Byron, P.A. is serving as Techne's legal counsel.Choate Hall & Stewart LLP is serving as Novus Biologicals' legal counsel.Transaction closed on July 2, 2014. 

Company Quote

0.86 +0.88%
6 May 2015